Curator's Take
AI Commentary
This article demonstrates the first heterogeneous quantum‑classical simulation of a protein‑ligand complex with more than 12 000 atoms, showing that near‑term quantum processors can already contribute useful electronic‑structure detail to drug‑binding calculations when paired with classical supercomputers. The new Embedded Wavefunction formalism and TrimSQD algorithm extend the size frontier beyond previous ~100‑atom quantum chemistry benchmarks, building on recent advances in hybrid quantum methods such as QM/MM and variational embedding. While the approach still relies on a large classical workload and error‑mitigated 156‑qubit hardware, it provides a concrete pathway toward quantum advantage in pharmaceutical modeling as devices scale.
— Mark Eatherly
Summary
A collaboration between Cleveland Clinic, RIKEN, and IBM Quantum has achieved the largest heterogeneous quantum-classical (HQC) electronic-structure calculation to date, simulating protein-ligand complexes exceeding 12,000 atoms. This research utilized 156-qubit IBM Heron r2 processors and leadership supercomputers to significantly advance molecular size and fragment energy accuracy in drug binding simulations. The team developed an Embedded Wavefunction (EWF) formalism and TrimSQD to efficiently handle these complex calculations, leading to the first HQC protein-ligand binding energy prediction. The post Cleveland Clinic, RIKEN, and IBM Cross 12,000-Atom Barrier in Heterogeneous Quantum-Classical Drug Binding Simulations appeared first on Quantum Computing Report .